Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-000418-39Phase 3Completed
Phase 3, randomised trial of linagliptin and metformin in prediabetes and hyperglycemia (4 arms), sponsored by Evidem Consultores. Primary endpoint: Microvascular complication index. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-000418-39.